Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in mozambican infants: A randomized, placebo-controlled trial

Journal of Infectious Diseases

Volumn 194, Issue 3, 2006, Pages 276-285

  Macete, Eusebio ^a,b   Aide, Pedro ^a,c   Aponte, John J ^a,d   Sanz, Sergi ^d   Mandomando, Inacio ^a,c   Espasa, Mateu ^a,d   Sigauque, Betuel ^a,c   Dobaño, Carlota ^d   Mabunda, Samuel ^b   DgeDge, Martinho ^b   Alonso, Pedro ^a,d   Menendez, Clara ^a,d,e  

^a Ministérioda Saúde   (Mozambique)

^b MINISTRY OF HEALTH   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^d UNIVERSITY OF BARCELONA   (Spain)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMODIAQUINE; BILIRUBIN; CHLOROQUINE; CREATININE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; FANSIDAR; HEMOGLOBIN; HEPATITIS B VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PLACEBO; TETANUS TOXOID; VACCINE;

ANEMIA; ANOPHELES; ANTHROPOMETRY; ARTICLE; BED NET; BLOOD CELL COUNT; BLOOD CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEATH; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MORBIDITY; MOZAMBIQUE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SPLENOMEGALY; STATISTICAL ANALYSIS; VACCINATION; VOMITING;

ANIMALS; ANTIMALARIALS; CHEMOPREVENTION; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLACEBOS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE;

EID: 33746380284     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505431     Document Type: Article

References (22)

1. World Health Organization. World malaria report 2005. Available at: http://rbm.who.int/wmr2005/. Accessed December 2005.
2. Geerligs PD, Brabin BJ, Eggelte TA. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ 2003; 81:205-16.
3. Pringle G, Avery-Jones S. Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection. Bull World Health Organ 1966; 34:269-72.
4. Menendez C, Kahigwa E, Hirt R, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997; 350:844-50.
5. Hogh B, Thompson R, Lobo V, et al. The influence of maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique. Acta Trop 1994; 57: 265-77.
6. Schellenberg D, Menendez C, Kahigwa E, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001; 357:1471-7.
7. IPTi Consortium. Intermittent preventive treatment in infants (IPTi) with antimalarial drugs delivered through the Expanded Programme on Immunization (EPI). Available at: http://www.ipti-malaria.org. Accessed December 2005.
8. INDEPTH Network. Population and health in developing countries. Ottawa, Canada: International Development Research Centre, 2002.
9. Abacassamo F, Enosse S, Aponte JJ, et al. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Trop Med Int Health 2004; 9:200-8.
10. Loscertales MP, Roca A, Ventura PJ, et al. Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr Infect Dis J 2002; 21:148-55.
11. Phillips-Howard PA, West LJ. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J R Soc Med 1990; 83:82-5.
12. Alonso PL, Smith T, Schellenberg JR, et al. Randomised trial of efficacy of spf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994; 344:1175-81.
13. Saute F, Aponte J, Almeda J, et al. Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhica District. Trans R Soc Trop Med Hyg 2003; 97:661-6.
14. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(S1):1-90.
15. Vidmar S, Carlin J, Hesketh K. Standardizing anthropometric measures in children and adolescents with new functions for age. Stata J 2004; 4: 50-5.
16. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004; 364:1411-20.
17. Villena I, Quereux C, Pinon JM. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination. Prenat Diagn 1998; 18:754-6.
18. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-22.
19. Florez J, Armijo JA. Farmacología humana. 4th ed. Madrid: Masson, 2003.
20. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am J Trop Med Hyg 2004; 70:1-7.
21. Spencer HC, Kaseje DC, Mosley WH, Sempebwa EK, Huong AY, Roberts JM. Impact on mortality and fertility of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol 1987; 81(Suppl 1):36-45.
22. Lengeler C. Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev 2000; (2):CD000363.